- Home
- ORN vs AUTL Comparison
ORN vs AUTL Comparison
Compare ORN & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ORN | AUTL |
|---|---|---|
| Founded | 1994 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 411.7M | 431.2M |
| IPO Year | 2007 | 2025 |
Fundamental Metrics
Financial Performance| Metric | ORN | AUTL |
|---|---|---|
| Price | $11.87 | $1.48 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $16.25 | $8.50 |
| AVG Volume (30 Days) | 288.0K | ★ 1.7M |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 220.00 | N/A |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $852,260,000.00 | $10,120,000.00 |
| Revenue This Year | $8.50 | $84.74 |
| Revenue Next Year | $7.83 | $65.76 |
| P/E Ratio | $197.67 | ★ N/A |
| Revenue Growth | 7.01 | ★ 496.00 |
| 52 Week Low | $5.68 | $1.15 |
| 52 Week High | $15.00 | $2.70 |
Technical Indicators
Market Signals| Indicator | ORN | AUTL |
|---|---|---|
| Relative Strength Index (RSI) | 55.50 | 54.72 |
| Support Level | $9.85 | $1.45 |
| Resistance Level | $13.17 | $1.52 |
| Average True Range (ATR) | 0.48 | 0.08 |
| MACD | 0.17 | 0.02 |
| Stochastic Oscillator | 83.33 | 80.25 |
Price Performance
Historical ComparisonAbout ORN Orion Group Holdings Inc.
Orion Group Holdings Inc is a specialty construction company serving the infrastructure, industrial, and building sectors, providing services both on and off the water in the continental United States, Alaska, Canada, and the Caribbean Basin through its marine segment and its concrete segment. Its marine segment provides construction and dredging services relating to marine transportation facility construction, marine pipeline construction, marine environmental structures, dredging of waterways, channels and ports, environmental dredging, design, and specialty services. The concrete segment generates maximum revenue and provides construction services for commercial, industrial, multi-family residential, and public projects, including the data center market.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.